Fundamentals Overview
Elevance Health Inc. is near the high of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+197.2% upside vs price
Profitability
Risk (Beta)
0.67 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +197.2% upside vs price · 3M vs S&P 500: +9.8% · 3M vs Healthcare sector: +24.3%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $1,168.75; current price is $393.19. That’s a +197.2% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 16.53 |
| DCF value (model) | $1,168.75 (197.2% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.97 |
| P/S (TTM) | 0.43 |
| P/FCF (TTM) | 13.24 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.48 |
| Quick Ratio (TTM) | 1.48 |
| Cash Ratio (TTM) | 0.21 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 2.62% |
| Gross margin (TTM) | 23.16% |
| Operating margin (TTM) | 3.81% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ELV.
Stock Grades (Institutions)
No stock grades available for this symbol.